Ascletis Pharma Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Ascletis Pharma stock has a consensus rating of "Buy" and an average price target of $23.95. The average 1-year stock price forecast is 142.41% higher than the current stock price, while the lowest is $15.98 (+61.74%) and the highest is $31.92 (+223.08%).

Price Target: $23.95 (+142.41%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15.98	$23.95	$23.95	$31.92
Change	+61.74%	+142.41%	+142.41%	+223.08%

* Price targets were last updated on Apr 7, 2026.

Analyst Ratings

The average analyst rating for Ascletis Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	4	3	2	2	1	1
Buy	1	1	1	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	5	4	3	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Orient Securities No rating	Orient Securities	Buy Maintains $24.63	Buy	Maintains	$24.63	+149.29%	Apr 7, 2026
Unknown Analyst Goldman Sachs No rating	Goldman Sachs	Hold Maintains $13.76 → $15.71	Hold	Maintains	$13.76 → $15.71	+59.01%	Apr 3, 2026
Wangbin Zhou Citi	Citi	Buy Reiterates $32.00	Buy	Reiterates	$32.00	+223.89%	Feb 3, 2026

Financial Forecast

Revenue This Year

804.38M

from 2.03M

39,563.46%

from 2.03M

Revenue Next Year

70.02M

from 804.38M

-91.29%

from 804.38M

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	76.88M	54.09M	56.60M	1.28M	2.03M	804.38M
Revenue Growth	119.64%	-29.64%	4.63%	-97.73%	58.07%	39,563.46%
Gross Profit	39.17M	-24.69M	25.99M	735.00K	527.00K	723.94M
Gross Margin	50.96%	-45.65%	45.92%	57.29%	25.99%	90.00%
Operating Income	-230.47M	-348.62M	-308.95M	-404.63M	-484.53M	363.94M
Net Income	-199.02M	-314.84M	-144.72M	-300.94M	-359.88M	407.69M
No. Analysts	-	-	-	-	-	2

Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	1.6B
Avg	804.4M
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	79,226.9%
Avg	39,563.5%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-